binx health Enters into Distribution Agreement for National Launch of the FDA-cleared binx io
binx molecular point-of-care platform poised to transform care for chlamydia and gonorrhea, the two most tested for sexually-transmitted infections
News
New York Film Academy Selects binx health for COVID-19 Testing, Creating Instant Platform for Broad Health Offerings Across Multiple Campuses
binx positioned to “switch on care at scale” in New York, Los Angeles and Miami
binx health receives EUA authorizing At-Home COVID-19 sample collection by universities and employers
Latest amendment adds important tool for student health and employers in the fight against COVID-19
College health insurer Wellfleet teams up with binx health to keep students safe and campuses open in the fight against COVID-19
Wellfleet taps binx for convenient, in-dorm sample collection and bespoke technology solutions to help arrest virus spread
Sherlock Biosciences and binx health Announce Global Partnership to Develop First CRISPR-based Point-of-care Test for COVID-19
binx health’s Proven Molecular io Platform Combined with SHERLOCK™ CRISPR Technology Will Enable Rapid, Accurate Testing for SARS-CoV-2 in Retail and Near-patient Settings
binx health and UPS Jointly Announce International Partnership for At-home “Contactless” COVID-19 Sample Collection
Binx and UPS Healthcare pair advanced infectious disease testing with superior global logistics to reach populations everywhere, starting in the United Kingdom
binx health Announces Publication of Pivotal Study in JAMA Network Open
Study signals “real paradigm shift” in care resulting from the world’s first FDA-cleared, 30-minute, molecular point-of-care platform for the detection of chlamydia and gonorrhea
binx health Announces Second FDA 510(k) Clearance of its Molecular Point-of-Care Infectious Disease Platform
Latest FDA clearance establishes binx as the fastest dual-gender rapid test-and-treat platform for chlamydia and gonorrhea
COVID-19 pandemic has created growing backlog of millions in need of routine STI testing
Fortune Magazine featured binx health’s io as a healthcare “breakthrough,” as it expands access to high quality chlamydia and gonorrhea testing at point of care sites across the US
binx health was featured in Fortune Magazine highlighting the io platform as not only the first and fastest FDA-cleared molecular point-of-care diagnostic for the detection of chlamydia and gonorrhea, but…